Nevertheless, decisions should always consider the complete safety profile of the drug, patient preferences and cost-effectiveness in certain health care settings. Researchers conducted a network meta-analysis of randomized controlled trials that assessed a maintenance dose of 5 mg, 10 mg or 15 mg once-weekly tirzepatide (Mounjaro, Eli Lilly) or 0.5 mg, 1 mg or 2 mg once-weekly subcutaneous semaglutide (Wegovy, Novo Nordisk) compared with placebo for at least 12 weeks
A medical assistant will follow up with you every 4-6 weeks to discuss your dosage and facilitate your success
But based on the currently available data, it doesnt seem to increase the risk of these conditions
Nutrient Absorption and Vitamin Deficiencies One of the most overlooked risks of orlistat is how it affects your nutrition
And more importantly, these medications started changing how clients approach fitness
Encouraging open communication also helps identify issues early